Global Hemodialysis Market to Reach US$ 126.7 Billion by 2032, Accelerated by Rising Prevalence of Chronic Kidney Diseases (CKD)

As per the latest report by IMARC Group, titled "Hemodialysis Market Report by Segment (Hemodialysis Product, Hemodialysis Service), Modality (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), End-User (Hospitals, Independent Dialysis Centres, and Others), and Region 2024-2032," the global hemodialysis market size reached US$ 90.7 Billion in 2023. Hemodialysis is a treatment option for individuals with end-stage renal disease (ESRD) or acute kidney injury. It involves the purification of blood using a dialysis machine, serving as an artificial kidney. It primarily removes waste products, excess fluid, and toxins from the bloodstream, thereby restoring the body's chemical balance. During hemodialysis, the patient's blood is diverted through a dialyzer, a filter-like component within the dialysis machine. The dialyzer consists of a semipermeable membrane that allows the passage of waste products and excess fluid while retaining vital blood components. One of the primary advantages of hemodialysis is its ability to efficiently eliminate waste products and regulate fluid balance, providing relief from symptoms associated with kidney failure. Furthermore, it can be performed at specialized dialysis centers or home, offering flexibility and convenience for patients. In comparison to peritoneal dialysis, it provides more rapid and effective removal of toxins from the body. Currently, there are different types of hemodialysis treatment available, including conventional hemodialysis and hemodiafiltration.

Global Hemodialysis Market Trends:

The global hemodialysis market is primarily influenced by the rising prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) across the globe. This is further supported by the increasing geriatric population more susceptible to such ailments. Moreover, the growing number of dialysis centers and significant advancements in hemodialysis technologies, such as the introduction of high-flux dialyzers and online hemodiafiltration systems, are boosting the market growth. The rising healthcare expenditure and availability of favorable reimbursement policies for dialysis treatments are also propelling the market growth. Additionally, the surging awareness about renal care, the availability of portable and home hemodialysis devices, and the growing adoption of telemedicine for remote monitoring of dialysis patients are contributing to the market growth. Moreover, burgeoning investments in research and development (R&D) activities to improve the efficacy and safety of hemodialysis procedures, along with the emergence of wearable artificial kidneys and bioengineered blood vessels, are providing an impetus to the market growth. Furthermore, the integration of artificial intelligence (AI) in hemodialysis machines is creating a positive outlook for the market. Apart from this, the rising prevalence of diabetes and hypertension, the increasing demand for home-based hemodialysis, and surging mergers and acquisitions activities among key market players are favoring the market growth. Looking forward, the market value is projected to reach US$ 126.7 Billion by 2032, expanding at a CAGR of 3.7% during 2024-2032.

Market Summary: 

• By the segment, the market is segmented into hemodialysis product (machines, dialyzers, and others) and hemodialysis service (in-center services and home services). According to the report, hemodialysis service accounted for the largest market share.
• Based on the modality, the market is segregated into conventional, short daily, and nocturnal hemodialysis. According to the report, conventional hemodialysis accounted for the largest market share.
• On the basis of the end user, the market is divided into hospitals, independent dialysis centres, and others.
• By the region, the market has been categorized into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to the report, North America was the largest market for hemodialysis.
• The competitive landscape of the industry has also been examined with some of the key players being Baxter International, Asahi Kasei Corporation, B. Barun Melsungen, DaVita, Cantel Medical Corporation, Fresenius Medical Care, Nipro Corporation, Rockwell Medical, Medivators, Toray Medical Company Ltd., Nikkiso Co. Ltd., Surni Group, Gambro, Satellite Healthcare Inc., Renacon Pharma Ltd., etc.

Report Coverage:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800